JOHANNESBURG, July 26 (Reuters) – South Africa’s Aspen Pharmacare (APNJ.J) will supply the first batch of Johnson & Johnson (JNJ.N) COVID-19 vaccine to the country from July 26, it said on Monday.

The company, which has been contracted by J&J to manufacture the vaccines in South Africa, imports the drug substance from J&J and prepares it for supply in what is known as a fill and finish process.

The supplies will also be distributed to the other African countries, the company said.

Reporting by Promit Mukherjee
Editing by Tomasz Janowski

Our Standards: The Thomson Reuters Trust Principles.